SoftMining

Our Science

Drug and materials discovery pipelines

In addition to working with other companies, SoftMining has achieved important results in many areas. As you can see, we are active in the development of antibiotics, anticancer drugs, and biomaterials.

IP

Early discovery

Discovery

Preclinical

Phase I

Phase II 

Phase III

Laminar Pharma

BRC

SJT-SM

SM

SM

SM

Glioblastome
Breast cancer
NASH*
Bacteria 1*
Bacteria 2*
ADAR*

* Patent pending

IP

Early discovery

Proof of concept

Patent

Prototype

Market Ready

SM

SM

SM-Tecnocap

SM

Biodegradable controlled materials
Chemical synthesis on metal support
Biodegradable non toxic PVC replacement
Electrochemical treatment of bacteriousys

APP's pipeline

This represents a side effect of SoftMining research. It all started with the Covid emergency. SoftMining proposed and built (in team with other startups) the first European contact tracing app SM-Covid-19. We were present on Google and Apple stores since April 2020 thanks to the support of Regione Campania (Italy). We filed two patents related to Bluetooth technologies and developed, in record time, multiplatform solutions to support communities in containing the virus. These assets can be sourced or licensed to other companies.

Type

Download

Proof of concept

Prototype

Market Ready

BLE Contact tracing

Tourism assistant

Risk assessment

Social Platform

ECG analysis

Semantic analysis

> 0
> 0
> 0

Web

Web

SM-Covid-19
WIT
Convivio*
WIT+*
EKG*
SySA

* Patent pending